BeStock  
Markets › Compare › IDYA vs SLS

IDYA vs SLS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
IDYA · IDEAYA Biosciences$25.56 ▼ 2.33%
SLS · Sellas Life Sciences$13.66 ▼ 8.08%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

43296559801305Nov 24, '25May 26, '26Nov 20, '26
  • IDYA -26.3%
  • SLS +781.3%

Head to head

MetricIDYASLS
Price$25.56$13.66
Change today▼ 2.33%▼ 8.08%
Market cap$2.47B$2.78B
Return, 3 months-36.2%-4.7%
Return, year to date-26.1%+262.3%
Return, 1 year-24.8%+792.8%
P/E (TTM)––
P/B2.321.1
P/E percentile vs own 5y83rd8th
Dividend yield––
Revenue growth (YoY, latest qtr)-95.1%–
Net profit growth (YoY)-205.5%-48.6%
Gross margin––
Operating margin-1,267.3%–
Net margin-1,149.6%–
Return on equity-38.5%-40.3%
Analyst target vs. price+107.0%+119.6%
Analyst buy share100%100%
RSI (14)2556
30-day volatility52.8%304.0%
Max drawdown, 1 year-39.8%-51.7%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • SLS is the largest of the group by market value.
  • SLS has returned the most over the past year.
  • IDYA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top